Motivity, a U.S.-based provider of clinical data collection solutions for applied behavior analysis (ABA) therapy, signed a definitive agreement to acquire Calmanac, an enterprise practice management software company also based in the United States. The deal is expected to close on May 22, 2026.

Acquirer:Motivity
Target:Calmanac
Type of Deal:Acquisition
Value:Undisclosed
Closing Date:May 22, 2026

Deal Mechanics

Motivity and Calmanac have entered into a definitive agreement to combine their offerings in the ABA therapy market. The acquisition aims to create a unified platform that integrates Motivity's clinical data collection capabilities with Calmanac's enterprise practice management solutions.

Financial terms of the transaction were not disclosed. Neither party provided details on key deal terms, including purchase price and payment structure, or financial advisors involved in the negotiations.

Strategic Rationale

The acquisition is designed to enhance Motivity's position as a comprehensive provider of technology solutions for ABA therapy practices. By combining Calmanac’s software suite with its own clinical data collection tools, Motivity aims to offer a complete end-to-end solution that streamlines the delivery of ABA services.

Financial Context

Motivity has previously raised capital through Five Elms Capital and leveraged these funds to build out its ABA technology stack. Calmanac's enterprise software platform complements Motivity’s existing offerings by providing advanced analytics, financial management tools, and client engagement solutions.

Advisors

The details of the financial advisors and legal counsel representing both parties in the acquisition were not disclosed at this time.

Outlook

Motivity's CEO emphasized that this acquisition is a strategic step to solidify Motivity’s leadership position within the ABA technology sector. The combined entity aims to drive innovation, enhance service delivery, and address the growing demand for efficient and effective patient care in the expanding behavioral health market.